Press release
Pranlukast Market Expected to Hit USD 2.58 Billion by 2032 with a Remarkable 4.18% CAGR
Market Overview
Pranlukast belongs to a class of anti-asthmatic medications that works by blocking leukotrienes, inflammatory chemicals involved in the pathophysiology of asthma and allergic conditions. While widely used in several Asian countries including Japan and South Korea, the drug is increasingly being explored in new markets for its efficacy, safety profile, and role in combination therapies.
Growing awareness about asthma management, coupled with the increasing demand for personalized medicine and long-term respiratory care, is contributing to the gradual expansion of the Pranlukast market across developing and emerging economies.
As per MRFR analysis, the Pranlukast Market Size was estimated at 1.68 (USD Billion) in 2023.The Pranlukast Industry is expected to grow from 1.78(USD Billion) in 2024 to 2.58 (USD Billion) by 2032. The Pranlukast Market CAGR (growth rate) is expected to be around 4.18% during the forecast period (2024 - 2032).
Request Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart :
https://www.marketresearchfuture.com/sample_request/27136
Market Growth
The Pranlukast market is projected to grow steadily over the coming years, supported by:
• Rising prevalence of asthma, particularly in urban populations and children
• Increased access to generic and branded formulations in Asia-Pacific and Latin America
• Growing emphasis on maintenance therapies for chronic respiratory diseases
Expansion of online pharmacies and telemedicine
boosting prescription rates in rural and semi-urban areas
Moreover, pharmaceutical companies are investing in clinical trials to explore Pranlukast's potential beyond asthma treatment, including applications in atopic dermatitis and inflammatory bowel disease, further expanding its market scope.
Key Companies in the Pranlukast Market Include:
• Intas Pharmaceuticals Ltd.
• Mylan N.V.
• Cadila Healthcare Limited
• Teva Pharmaceutical Industries Ltd.
• Ipca Laboratories Ltd.
• Sandoz International GmbH
• Emcure Pharmaceuticals Ltd.
• Torrent Pharma
• Glenmark Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Ltd.
• AstraZeneca
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.
• Aurobindo Pharma Limited
• Lupin
Market Dynamics
Key Drivers
• High global burden of respiratory disorders: Asthma affects over 250 million people globally, creating consistent demand for bronchodilator and leukotriene-modifying agents.
• Preference for oral therapies: Pranlukast's oral administration makes it preferable for long-term use, especially in pediatric care.
• Generic availability: Generic drug manufacturers are entering the market, making treatment more affordable and accessible.
Challenges
• Limited approval in Western markets: Pranlukast is not yet approved in the US and many parts of Europe, which restricts global adoption.
• Competition from alternative therapies: Drugs like montelukast dominate many regions, posing a challenge to market penetration.
• Side-effect concerns: Though generally well-tolerated, some leukotriene antagonists have been linked to neuropsychiatric side effects, affecting physician prescribing habits.
Direct Purchase this Research Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=27136
Pranlukast Market Segmentation
• Pranlukast Treatment Type Outlook
• Asthma
Chronic Obstructive Pulmonary Disease (COPD)
• Pranlukast Drug Formulation Outlook
• Tablets
• Suspension
• Inhalers
Pranlukast Distribution Channel Outlook
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Pranlukast Dose Strength Outlook
• 75 mg
• 150 mg
• 300 mg
Pranlukast Regional Outlook
• North America
• Europe
• South America
• Asia Pacific
• Middle East and Africa
Future Outlook
The global Pranlukast market is expected to witness moderate but consistent growth through 2032. Market expansion is likely to be strongest in Asia-Pacific, where the drug is already established, with new growth opportunities in Latin America, Africa, and Eastern Europe due to increasing healthcare investments and awareness.
Comprehensive Overview: https://www.marketresearchfuture.com/reports/pranlukast-market-27136
Future growth will also depend on:
• Regulatory approvals in new geographies
• Innovative fixed-dose combinations with inhaled corticosteroids
• Research into additional indications, broadening its clinical utility
• Digital health tools enhancing prescription and patient compliance
Reasons to Buy the Pranlukast Market Report
✔️ In-depth analysis of market size, forecast, and competitive landscape
✔️ Insights into regional growth patterns and market accessibility
✔️ Assessment of key players, generic drug opportunities, and pipeline developments
✔️ Evaluation of emerging therapeutic applications for pranlukast beyond asthma
✔️ Strategic guidance for pharmaceutical firms, distributors, and investors entering respiratory care markets
The Pranlukast Market presents promising opportunities in respiratory and allergy therapeutics, especially in underserved regions. With a growing focus on long-term asthma control and generic drug expansion, stakeholders who invest early in this segment stand to benefit from consistent demand and innovation in the years ahead.
FAQs
What is driving the growth of the Pranlukast market?
Which regions dominate the Pranlukast market?
What are the main challenges facing the Pranlukast market?
What are the potential growth opportunities for Pranlukast in the future?
Who are the major players in the Pranlukast market?
Related Reports
AI in Medical Writing Market: https://www.marketresearchfuture.com/reports/ai-medical-writing-market-31280
Artificial Intelligence In Animal Health Market: https://www.marketresearchfuture.com/reports/artificial-intelligence-animal-health-market-31244
Acute Wound Care Market: https://www.marketresearchfuture.com/reports/acute-wound-care-market-8844
Pharma Social Media Market: https://www.marketresearchfuture.com/reports/pharma-social-media-market-32048
Bone Void Fillers Market: https://www.marketresearchfuture.com/reports/bone-void-filler-market-32038
Healthcare Interoperability Solution Market: https://www.marketresearchfuture.com/reports/healthcare-interoperability-solution-market-31976
Chiropractic Care Market: https://www.marketresearchfuture.com/reports/chiropractic-care-market-32293
Clinical Trial Supplies Market: https://www.marketresearchfuture.com/reports/clinical-trial-supplies-market-9183
Colorectal Cancer Screening Market: https://www.marketresearchfuture.com/reports/colorectal-cancer-screening-market-9203
Dental Cements Market: https://www.marketresearchfuture.com/reports/dental-cement-market-9274
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. MRFR's approach combines the proprietary information with various data sources to give an extensive understanding to the client about the latest key developments, expected events and also about what action to take based on these aspects.
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pranlukast Market Expected to Hit USD 2.58 Billion by 2032 with a Remarkable 4.18% CAGR here
News-ID: 4104910 • Views: …
More Releases from Market Research Future
Human Microbiome Modulator Market Set for Explosive Growth: Poised to Reach USD …
The global Human Microbiome Modulator market is experiencing a dramatic transformation. Recent forecasts from Market Research Future (MRFR) indicate that this industry is projected to surge from approximately USD 2.33 billion in 2025 to USD 13.37 billion by 2034, registering a robust Compound Annual Growth Rate (CAGR) of 21.44 percent over the nine-year forecast period.
Download the Sample PDF Brochure to Get Started - https://www.marketresearchfuture.com/sample_request/37124
Growing Awareness of Gut-Health Impact
Consumers and…
Healthcare Digital Twin Market Set to Reach USD 179.53 Billion, with a Healthy 3 …
Healthcare Digital Twin Market Overview:
Healthcare Digital Twin Market Research Report By Component (Software, Services, Hardware), By Deployment Model (On-premise, Cloud-based, Hybrid), By Application (Medical Device Development, Drug Discovery & Development, Clinical Trial Optimization, Personalized & Precision Medicine, Remote Patient Monitoring, Surgical Planning & Simulation, Hospital Management, Healthcare Research & Innovation), By End-use Industry (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic & Research Institutions) and By Regions…
Cardiovascular Medical Device Market Poised to Grow to USD 74.59 Billion by 2034 …
The global cardiovascular medical device market is expected to witness steady and sustained growth over the next decade, with projections estimating it will reach a valuation of USD 74.59 billion by 2034. This growth reflects a compound annual growth rate (CAGR) of 3.93 percent, driven by rising incidences of cardiovascular diseases, advancements in medical technology, aging global populations, and improved healthcare infrastructure across both developed and emerging economies.
Download the Sample…
Healthcare BPO Market Anticipated to Reach USD 0.28 Billion, at a Notable 10.01% …
The Healthcare BPO Market is experiencing a transformative surge as healthcare providers, payers, and pharmaceutical firms increasingly outsource non-core functions to specialized service providers. With rising pressure to reduce operational costs, enhance service delivery, and comply with evolving regulations, business process outsourcing has emerged as a strategic tool to streamline healthcare operations worldwide.
As per MRFR Analysis, the Healthcare BPO Market was valued at USD 0.11 billion in 2023 and is…
More Releases for Pranlukast
Anti-Asthma Drugs Market Compressive Study 2018 by Foremost Players GlaxoSmithKl …
“Anti-Asthma Drugs Market” Report Exclusively Available at MarketReseacrhFuture.com with Unique Research information. Report covered In a Segregated way like Segmentation with sub segments, Growth Barrier, Scope, Major Drivers, Renowned Players strategies and Mega Trends. Outlet till 2023
Anti-Asthma Drugs Market - Segmentation
The Global Anti-Asthma Drugs Market has been segmented on the basis of drug class, route of administration, therapy, trigger, type, and lastly, region. On the basis of drug class, this…
Anti-Asthma Drugs Market Anticipated To Touch USD 28.3 Billion Till 2023 with Wo …
Anti-Asthma Drugs Market - Segmentation
The Global Anti-Asthma Drugs Market has been segmented on the basis of drug class, route of administration, therapy, trigger, type, and lastly, region. On the basis of drug class, this market has been segmented into bronchodilators, corticosteroids, leukotriene antagonists, mast cell stabilizers, monoclonal antibody, and others. Bronchodilators have been further segmented into anticholinergics, beta agonists, and Xanthines.
Based on the route of administration, the market has been…
Anti Asthma Drugs Market 2018; Leading Players Baxter International, Baxter Inte …
The Global Anti-Asthma Drugs Market has been segmented on the basis of drug class, route of administration, therapy, trigger, type, and lastly, region. On the basis of drug class, this market has been segmented into bronchodilators, corticosteroids, leukotriene antagonists, mast cell stabilizers, monoclonal antibody, and others. Bronchodilators have been further segmented into anticholinergics, beta agonists, and Xanthines.
Based on the route of administration, the market has been segmented into inhaled, intravenous,…
Anti-Asthma Drugs Market Compressive Study 2018 by Foremost Players GlaxoSmithKl …
Anti-Asthma Drugs Market - Segmentation
The global anti-asthma drugs market has been segmented on the basis of drug class, route of administration, therapy, trigger, type, and lastly, region. On the basis of drug class, this market has been segmented into bronchodilators, corticosteroids, leukotriene antagonists, mast cell stabilizers, monoclonal antibody, and others. Bronchodilators have been further segmented into anticholinergics, beta agonists, and Xanthines.
Based on the route of administration, the market has been…
Anti-Asthma Drugs Market Anticipated To Touch USD 28.3 Billion Till 2023 with Wo …
Anti-Asthma Drugs Market - Overview
With the air pollution rising around the world, the number of asthma patients is also increasing. Therefore the market for the drugs necessary for its treatment is rising. Market Research Future (MRFR) has published a research report that envisions surge in the global anti-asthma drugs market with 5.94% CAGR (Compound Annual Growth Rate) between 2015 and 2022. In terms of cash, the market is expected to…
Alopecia Drugs Market Is Anticipated To Touch USD 28.3 Billion Till 2023 | By Ty …
The Report Gives the Clear Picture of Current Market Scenario which Includes Historical and Projected Market Size in Terms of Value and Volume, Technological Advancement, Macro Economical and Governing Factors in the Market.
Anti-Asthma Drugs Market - Segmentation
The global anti-asthma drugs market has been segmented on the basis of drug class, route of administration, therapy, trigger, type, and lastly, region. On the basis of drug class, this market has been segmented…
